We are pleased to announce that Nina Singh, MD, has been conferred the title of Emeritus Professor of Medicine retroactive to September 1, 2022. Dr. Singh’s contributions have had a major impact as an academic leader in the field of Transplant Infectious Diseases (TID). She has been a member of the University since 2001 and a tenured faculty member for 20 years. Dr. Singh is an international leader in the field of transplant infectious diseases. Her accomplishments as a researcher, physician, and educator are exceptional. She retired from the University on August 31, 2022.

Dr. Singh joined the VA Pittsburgh Healthcare System (VAPHS) in 1990 as a Transplant Infectious Diseases Physician. She rounded on VAPHS ID clinical service in keeping with the effort of her appointment; she provided additional service to the Transplant program at VAPHS. Dr. Singh was appointed to the rank of Associate Professor of Medicine in the tenure track in 2001 in the Division of Infectious Diseases, Department of Medicine, University of Pittsburgh. She received tenure in 2004. She was promoted to the rank of Professor of Medicine in 2010.

Dr. Singh is internationally recognized for her work in clinical and translational research, mainly in the field of opportunistic viral and fungal infections in transplant recipients. This area has been the foundation of her scholarly and academic activities for the past 30 years. Her long-term scientific career has focused primarily on cytomegalovirus (CMV). Dr. Singh’s research demonstrates a logical progression from carefully conducted natural history studies to interventional clinical trials to optimize prevention of CMV. Her research laid the infrastructure that made it possible to recruit patients in large-scale multicenter trials. Through the years, she has successfully administered these projects and has had a lead role in the development, funding, oversight, and completion of these studies and correlative mechanistic work. These studies have challenged the prevailing paradigm and standard practice of complete viral suppression with antiviral prophylaxis as the most effective strategy for CMV prevention.

Dr. Singh is recognized globally for her expertise in cytomegalovirus and opportunistic mycoses, in particular cryptococcosis in organ transplant recipients. She has a remarkable record of achievement as a funded scientist, collaborator, and mentor. She has also dedicated herself to service in a variety of ways both internal and external to the University. Dr. Singh is an outstanding role model for students, residents, fellows, and junior faculty. She has had an outstanding professional career with scholarly attainments that have contributed towards optimizing patient outcomes and the advancement of science. Dr. Singh has had a major impact as an academic leader in the field of transplant ID. Her legacy is exceptionally strong and enduring. We are extremely fortunate to have her as a faculty member and we are sure she will continue to contribute to the academic environment at the University of Pittsburgh.

Please join us in congratulating, Nina!